Literature DB >> 3075433

Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.

E Yourassowsky1, M P van der Linden, M J Lismont, F Crokaert, Y Glupczynski.   

Abstract

Enterobacter cloacae infections have been shown clinically to respond less reliably to monotherapy with broad-spectrum cephalosporins than was initially expected. Selection of populations producing high levels of beta-lactamase has been shown to be the most frequent reason for treatment failure, and the use of these agents with another active antibiotic is recommended. In this study, E. cloacae strains from clinical specimens susceptible to ceftazidime and amdinocillin by broth dilution and disk tests were examined. In the presence of ceftazidime at 10 micrograms/ml, in vitro selection of resistant organisms was demonstrated for 3 of 11 strains. Selection was prevented when amdinocillin was added in combination. A more rapid killing was also demonstrated with this combination. At inocula of 10(8) CFU/ml, ceftazidime-resistant populations were isolated from 6 of 11 strains in vitro, and the emergence of this resistance was prevented by amdinocillin. The enhanced killing effect noted for amdinocillin with ceftazidime may have resulted in part from complementary activity of the antibiotics on penicillin-binding proteins. The ceftazidime-amdinocillin combination offers an interesting prospect for the therapy of infections caused by E. cloacae strains which are initially susceptible to both antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3075433      PMCID: PMC175942          DOI: 10.1128/AAC.32.11.1632

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

2.  Newer mechanisms of resistance to beta-lactam antibiotics in gram-negative bacteria.

Authors:  L J Piddock; R Wise
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

3.  Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.

Authors:  S C Aronoff; D M Shlaes
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

4.  Inducing capacity of the combinations mecillinam-ampicillin and mecillinam-ceftazidime in comparison with the capacity of the compounds administered separately.

Authors:  E E Stobberingh; C P van Boven
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

5.  Development of beta-lactam-resistant Enterobacter cloacae in mice.

Authors:  B Marchou; M Michea-Hamzehpour; C Lucain; J C Pechère
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

6.  Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery.

Authors:  D M Flynn; R A Weinstein; C Nathan; M A Gaston; S A Kabins
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

7.  Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).

Authors:  L Gutmann; S Vincent; D Billot-Klein; J F Acar; E Mrèna; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

8.  Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.

Authors:  J P Quinn; C A DiVincenzo; J Foster
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

9.  Detection of PSE-2 beta-lactamase in enterobacteria.

Authors:  D M Livermore; J P Maskell; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

10.  In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.

Authors:  L Verbist
Journal:  J Antimicrob Chemother       Date:  1985-12       Impact factor: 5.790

View more
  1 in total

1.  Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci.

Authors:  G J Forstall; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.